Vimarsana
Biggest News Aggregation in the World

Page 7 - Cell Pouch System News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Cell Pouch System. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Cell Pouch System Today - Breaking & Trending Today

Evotec and Sernova announce exclusive strategic partnership for iPSC-based beta cell replacement therapy to advance a 'functional cure' for diabetes - Vimarsana News

Evotec and Sernova announce exclusive strategic partnership for iPSC-based beta cell replacement therapy to advance a 'functional cure' for diabetes

17.05.2022 Evotec and Sernova announce exclusive strategic partnership for iPSC-based beta cell replacement therapy to advance a 'functional cure' for diabetes | Evotec SE | News | Nachricht | Mitteilung

Source: dgap.de
Sernova and Evotec Enter into an Exclusive Global Strategic - Vimarsana News

Sernova and Evotec Enter into an Exclusive Global Strategic

Partnership Leverages Sernova’s Proprietary Cell Pouch System™ with Evotec’s iPSC-Based Insulin-Producing Beta CellsPartners to Develop and Commercialize...

Sernova Ranks Among Top 50 Performing Companies on the 2022 TSX Venture List - Vimarsana News

Sernova Ranks Among Top 50 Performing Companies on the 2022 TSX Venture List

DGAP-News: Sernova Corp. / Key word(s): Miscellaneous24.02.2022 / 13:31 The issuer is solely responsible for the content of this announcement.Sernova awarded top performer status for two years standingLONDON, ONTARIO - February 24, 2022 - Sernova Corp. (TSX-V:SVA) (OTCQB:SEOVF) (FSE/XETRA:PSH), a clinical-stage rege...

Sernova to Announce New Interim Results of its Type 1 Diabetes Clinical Trial During the 40th Annual - Vimarsana News

Sernova to Announce New Interim Results of its Type 1 Diabetes Clinical Trial During the 40th Annual

DGAP-News: Sernova Corp. / Key word(s): Study results/Study05.01.2022 / 15:25 The issuer is solely responsible for the content of this announcement.LONDON, ONTARIO - January 5, 2022 - Sernova Corp. (TSX-V:SVA) (OTCQB:SEOVF) (FSE/XETRA:PSH), a clinical-stage regenerative medicine and cell therapy therapeutics company...

Sernova Announces Clinical Investigator Update of its Type 1 Diabetes Trial at the 2022 ASTS 22nd An - Vimarsana News

Sernova Announces Clinical Investigator Update of its Type 1 Diabetes Trial at the 2022 ASTS 22nd An

DGAP-News: Sernova Corp. / Key word(s): Study results/Conference16.12.2021 / 12:05 The issuer is solely responsible for the content of this announcement.LONDON, ONTARIO - December 16, 2021 - Sernova Corp. (TSX-V:SVA) (OTCQB:SEOVF) (FSE/XETRA:PSH), a clinical-stage regenerative medicine and cell therapy therapeutics...